TrialToxins2023

Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.

Francesco Bono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.